• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Germany-Based Haselmeier Inc. Opens Lowell, Massachusetts, Operations Center

A global medical device company and a leading designer and manufacturer of pen and auto injection systems, Haselmeier Inc. will open its new office in the Boott Cotton Mills at 126 John Street, Suite 11, in Lowell, Massachusetts.

A downtown Lowell landmark and part of the Lowell National Park, the newly restored, historic 19th century textile mill is strategically located 25 miles north of Boston, between Logan International Airport and Manchester Boston Regional Airport.

According to company officials, the new location provides easy access for US and international clients, vendors and visitors. The move stems from Haselmeier's growth in the last year and will enable Haselmeier to maintain closer contact with its customers.

"The relocation offers Haselmeier Inc. access to leading pharmaceutical companies and leading research universities. The new office permits Haselmeier to achieve a greater presence in the medical device industry in the US and offer our US customers a higher level of support," commented Robert Kilgore, President, Haselmeier Inc. Terry O'Hagan, Director Business Development added, "Our move to Lowell, Massachusetts, will accommodate the continued growth of our US business. The space will accommodate increased staff and has been designed to create open, collaborative workspaces for our design teams. Varied meeting and conference spaces will provide our clients with a higher level of service,”.

Lowell, Massachusetts was chosen for its central location within a growing medical device region and its close proximity to the University of Massachusetts Lowell with its globally recognized engineering programs, the company said. Lowell is also home to M2D2, the Massachusetts Medical Device Development Center, a collaboration of State, Private and Academic resources supporting emerging medical technology and device start-ups.


Exclusive Research